.claude/skills/monitor-adc-patents-weekly-lsRuntime, accounts, dependencies, permissions, network behavior and task quality remain untested.
Create an evidence-backed weekly monitor of newly published antibody-drug conjugate (ADC) patent applications. Use when a user asks for an ADC patent weekly, new WO/PCT publications, emerging ADC targets or technologies, priority claim comparisons, or a shortlist of records that warrant claim review.
These states come from the source or distribution context. None of the entries below are SkillVetAI compatibility test results.
These checks parse the fixed package against dated platform rules. They do not execute the Skill or verify task behavior.
.claude/skills/monitor-adc-patents-weekly-lsRuntime, accounts, dependencies, permissions, network behavior and task quality remain untested.
.agents/skills/monitor-adc-patents-weekly-lsRuntime, accounts, dependencies, permissions, network behavior and task quality remain untested.
skills/monitor-adc-patents-weekly-lsRuntime, accounts, dependencies, permissions, network behavior and task quality remain untested.
This command is recorded from the source ecosystem and resolves the registry's latest release. The fixed release shown on this page should be inspected before adoption.
clawhub install @yuanzhian-patsnap/monitor-adc-patents-weekly-lsclawhub inspect @yuanzhian-patsnap/monitor-adc-patents-weekly-ls --version 1.0.0This automated, non-executing scan is bound to this release hash. It is not a safety certification and may contain false positives or false negatives.
This is registry-supplied evidence for the recorded release, not an independent SkillVetAI scan. Check the canonical source for the full report, scanner versions, scope, and current moderation state.
The catalog stores hashes and an inventory summary for change detection. It does not republish the package contents.
sha256:1d3754f51ee6e5eb720397f9838a7e7daf83de3c071f9e665ac43b493cf82bb9skill-card.mdSKILL.mdVersion 1.0.0 - Initial release of weekly monitoring for newly published antibody-drug conjugate (ADC) patent applications. - Supports two-stage screening to remove noise and prioritize relevant disclosures. - Defines clear input requirements, search protocol, and decision criteria for reproducible reporting. - Integrates with PatSnap MCP patent and drug intelligence connectors, plus optional pharmaceutical news context. - Provides eligibility and exclusion rules, claim relevance classes, and reporting best practices for IP and R&D teams.